AKUMS DRUGS & PHARMACEUTICALS
Back to Income Statement
|
AKUMS DRUGS & PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹4,118 Cr | ₹4,178 Cr | ₹3,655 Cr | ₹3,672 Cr | ₹2,723 Cr |
What is the latest Revenue of AKUMS DRUGS & PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹4,118 Cr |
| Mar2025 | ₹4,178 Cr |
| Mar2024 | ₹3,655 Cr |
| Mar2023 | ₹3,672 Cr |
| Mar2022 | ₹2,723 Cr |
How is Revenue of AKUMS DRUGS & PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹4,118 Cr | -1.44 | |
| Mar2025 | ₹4,178 Cr | 14.32 | |
| Mar2024 | ₹3,655 Cr | -0.46 | |
| Mar2023 | ₹3,672 Cr | 34.87 | |
| Mar2022 | ₹2,723 Cr | - | |
Compare Revenue of peers of AKUMS DRUGS & PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| AKUMS DRUGS & PHARMACEUTICALS | ₹12,122.2 Cr | 3.6% | 12.5% | 58.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹458,249.0 Cr | 1.8% | -1.6% | 16.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | -1.2% | 17.3% | 38.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,891.0 Cr | -2.3% | -2% | 33.6% | Stock Analytics | |
| CIPLA | ₹115,927.0 Cr | 0.2% | 1.7% | -8.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,702.0 Cr | 1.2% | 3.6% | -7% | Stock Analytics | |
AKUMS DRUGS & PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| AKUMS DRUGS & PHARMACEUTICALS | 3.6% |
12.5% |
58.4% |
| SENSEX | -0.5% |
1.3% |
-4% |
You may also like the below Video Courses